Evidence map›Paper›PMID 26643252›Full record

ArticleMolecular cancer2015

A functional connectome: regulation of Wnt/TCF-dependent transcription by pairs of pathway activators.

Jamie Freeman, David Smith, Branko Latinkic, Ken Ewan, Lee Samuel, Massimo Zollo, Natascia Marino, Lorraine Tyas, Nick Jones, Trevor C Dale

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Gene expression and pathway analysis ofWorld journal of stem cells · 2016
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jamie FreemanSchool of Biosciences, Cardiff University, Museum Avenue, Cardiff, CF10 3AX, Wales, UK.
David SmithFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Branko LatinkicSchool of Biosciences, Cardiff University, Museum Avenue, Cardiff, CF10 3AX, Wales, UK.
Ken EwanSchool of Biosciences, Cardiff University, Museum Avenue, Cardiff, CF10 3AX, Wales, UK.
Lee SamuelSchool of Biosciences, Cardiff University, Museum Avenue, Cardiff, CF10 3AX, Wales, UK.
Massimo ZolloDepartment of Molecular Medicine and Biotechnology and Centro di Ingegneria Genetica e Biotecnologia Avanzate, Federico II, Via Pansini 5, 80131, Naples, Italy.
Natascia MarinoDepartment of Molecular Medicine and Biotechnology and Centro di Ingegneria Genetica e Biotecnologia Avanzate, Federico II, Via Pansini 5, 80131, Naples, Italy.
Lorraine TyasSchool of Biosciences, Cardiff University, Museum Avenue, Cardiff, CF10 3AX, Wales, UK.
Nick JonesDepartment of Mathematics, Imperial College, London, SW7 2AZ, UK.
Trevor C DaleSchool of Biosciences, Cardiff University, Museum Avenue, Cardiff, CF10 3AX, Wales, UK. daletc@cardiff.ac.uk.
Cardiff University · GBTecnologie Avanzate (Italy) · ITImperial College London · GBUniversity of London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D00117X/1Cancer Research UK 15937Cancer Research UK C368/A4545Cancer Research UK C368/A7990
6 · The paper itself

Abstract

backgroundWnt/β-catenin signaling is often portrayed as a simple pathway that is initiated by Wnt ligand at the cell surface leading, via linear series of interactions between 'core pathway' members, to the induction of nuclear transcription from genes flanked by β-catenin/TCF transcription factor binding sites. Wnt/β-catenin signaling is also regulated by a much larger set of 'non-core regulators'. However the relationship between 'non-core regulators' is currently not well understood. Aberrant activation of the pathway has been shown to drive tumorgenesis in a number of different tissues.

methodsMammalian cells engineered to have a partially-active level of Wnt/β-catenin signaling were screened by transfection for proteins that up or down-regulated a mid-level of TCF-dependent transcription induced by transient expression of an activated LRP6 Wnt co-receptor (∆NLRP).

results141 novel regulators of TCF-dependent transcription were identified. Surprisingly, when tested without ∆NLRP activation, most up-regulators failed to alter TCF-dependent transcription. However, when expressed in pairs, 27 % (466/1170) functionally interacted to alter levels of TCF-dependent transcription. When proteins were displayed as nodes connected by their ability to co-operate in the regulation of TCF-dependent transcription, a network of functional interactions was revealed. In this network, 'core pathway' components (Eg. β-catenin, GSK-3, Dsh) were found to be the most highly connected nodes. Activation of different nodes in this network impacted on the sensitivity to Wnt pathway small molecule antagonists.

conclusionsThe 'functional connectome' identified here strongly supports an alternative model of the Wnt pathway as a complex context-dependent network. The network further suggests that mutational activation of highly connected Wnt signaling nodes predisposed cells to further context-dependent alterations in levels of TCF-dependent transcription that may be important during tumor progression and treatment.

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorGene Expression Regulation, NeoplasticGene Regulatory NetworksHEK293 CellsHumansProtein Interaction MapsTCF Transcription FactorsTranscription, GeneticWnt ProteinsWnt Signaling PathwayXenopus laevisAntineoplastic AgentsTCF Transcription FactorsWnt Proteins

Identifiers

PMID26643252
PMCPMC4672529
OpenAlexW2192048945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.